In a follow-up to the Burkholdera cepacia, or B. cepacia outbreak linked to liquid docusate products, the Centers for Disease Control and Prevention (CDC) reported an additional nine cases in the past week, bringing the outbreak total to 58.
In addition, three additional states have reported infections related to this outbreak–8 states total as on Jul. 26.
On July 16, the U.S. Food and Drug Administration (FDA) announced that PharmaTech LLC, Davie, Florida voluntarily recalled all non-expired lots of Diocto Liquid, a docusate sodium solution distributed by Rugby Laboratories, Livonia, Michigan.
The agency confirmed the product has been contaminated with Burkholderia cepacia.
PharmaTech manufactures the oral liquid docusate sodium, which is distributed nationwide by Rugby with a Rugby label in one pint (473 mL) bottles.
Burkholderia cepacia is the name for a group or “complex” of bacteria that can be found in soil and water. Burkholderia cepacia bacteria are often resistant to common antibiotics. Burkholderia cepacia poses little medical risk to healthy people; however, it is a known cause of infections in hospitalized patients. People with certain health conditions, like weakened immune systems or chronic lung diseases (particularly cystic fibrosis), may be more susceptible to infections with Burkholderia cepacia.
Related:
